4.4 Article

Nitric Oxide is Involved in the Down-regulation of SOST Expression Induced by Mechanical Loading

Journal

CALCIFIED TISSUE INTERNATIONAL
Volume 94, Issue 4, Pages 414-422

Publisher

SPRINGER
DOI: 10.1007/s00223-013-9821-8

Keywords

-

Funding

  1. Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (Spanish Ministry of Health) [PI12/615]
  2. SEIOMM-FEIOMM
  3. IFIMAV

Ask authors/readers for more resources

Mechanical stimulation reduces sclerostin expression in rodents. However, few data are available about the effect of physical stimuli in human systems. Recently we observed that the demethylating agent AzadC induces SOST expression in bone cells. This allowed us in this study to explore the effect of mechanical loading on SOST expression by subjecting AzadC-treated human bone cells to pulsating fluid flow (PFF). PFF significantly decreased the AzadC-induced expression of SOST. This effect persisted for at least 24 h, and in fact SOST expression was lower at 24 h after PFF treatment than at 1 h after PFF treatment (PFF/static ratio 0.47 +/- A 0.04 vs. 0.63 +/- A 0.03 respectively, p = 0.03). The PFF-induced decrease in SOST expression was not due to a change in the methylation profile of the SOST promoter. However, PFF stimulated nitric oxide (NO) synthesis, which appeared essential for the PFF effect on SOST expression. In fact, the NO synthase inhibitor 1400 W prevented the effect of PFF on SOST expression. Moreover, the NO-donor SNAP decreased SOST mRNA in bone organ cultures. The conditioned medium (CM) of cells subjected to PFF induced a 38 +/- A 4 % decrease in SOST expression (p = 0.03) in static cultures and diminished the transcriptional activity of reporter vectors with the cloned SOST promoter (Static-CM: 1.47 +/- A 0.10 vs. PFF-CM: 0.78 +/- A 0.09, p = 0.02). This is consistent with a PFF-induced secretion of factors that modulate SOST. Our results suggest that NO and other soluble factors are involved in the inhibition of SOST expression by PFF.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Generation and characterization of two immortalized human osteoblastic cell lines useful for epigenetic studies

Flor M. Perez-Campo, Tobias May, Jeannette Zauers, Carolina Sanudo, Jesus Delgado-Calle, Jana Arozamena, Maria T. Berciano, Miguel Lafarga, Jose A. Riancho

JOURNAL OF BONE AND MINERAL METABOLISM (2017)

Article Endocrinology & Metabolism

Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor

Jesus Delgado-Calle, Xiaolin Tu, Rafael Pacheco-Costa, Kevin McAndrews, Rachel Edwards, Gretel G. Pellegrini, Kali Kuhlenschmidt, Naomie Olivos, Alexander Robling, Munro Peacock, Lilian I. Plotkin, Teresita Bellido

JOURNAL OF BONE AND MINERAL RESEARCH (2017)

Editorial Material Endocrinology & Metabolism

Osteoclasts Control Lipid Secretion to Regulate Breast Cancer Bone Metastasis

Jesus Delgado-Calle

ENDOCRINOLOGY (2017)

Article Biochemistry & Molecular Biology

MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production

Jesus Delgado-Calle, Benjamin Hancock, Elive F. Likine, Amy Y. Sato, Kevin McAndrews, Carolina Sanudo, Angela Bruzzaniti, Jose A. Riancho, James R. Tonra, Teresita Bellido

FASEB JOURNAL (2018)

Article Dentistry, Oral Surgery & Medicine

Molecular Basis for Craniofacial Phenotypes Caused by Sclerostin Deletion

J. Chen, X. Yuan, I. Pilawski, X. Liu, J. Delgado-Calle, T. Bellido, H. Turkkahraman, J. A. Helms

Summary: Genetic disorders can result in distinctive facial features, affecting diagnosis and treatment. Using a mouse model, this study found that mutations in the Sost gene led to abnormal bone growth, causing changes in facial skeletal morphology and size, suggesting a role for sclerostin signaling in modulating craniofacial morphology.

JOURNAL OF DENTAL RESEARCH (2021)

Article Multidisciplinary Sciences

Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23

Patrick L. Mulcrone, Shanique K. E. Edwards, Daniela N. Petrusca, Laura S. Haneline, Jesus Delgado-Calle, G. David Roodman

SCIENTIFIC REPORTS (2020)

Review Endocrinology & Metabolism

Role of Osteocytes in Cancer Progression in the Bone and the Associated Skeletal Disease

Manish Adhikari, Jesus Delgado-Calle

Summary: Cancer cells manipulate osteocytes to facilitate invasion and tumor progression in bone, disrupting physiological bone remodeling and leading to bone diseases. Targeting osteocytes and their derived factors has been shown to effectively interfere with the progression of cancer in the bone. The interaction between osteocytes and cancer cells is complex and further research is needed to understand it better.

CURRENT OSTEOPOROSIS REPORTS (2021)

Article Oncology

Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity

Hayley M. Sabol, Adam J. Ferrari, Manish Adhikari, Tania Amorim, Kevin McAndrews, Judith Anderson, Michele Vigolo, Rajwinder Lehal, Meloney Cregor, Sharmin Khan, Pedro L. Cuevas, Jill A. Helms, Noriyoshi Kurihara, Venkat Srinivasan, Frank H. Ebetino, Robert K. Boeckman, G. David Roodman, Teresita Bellido, Jesus Delgado-Calle

Summary: The development of a bone-targeted Notch inhibitor, BT-GSI, reduces tumor burden in multiple myeloma and effectively prevents cancer-induced bone destruction without causing the gastrointestinal toxicity associated with conventional Notch inhibitors.

CANCER RESEARCH (2021)

Review Physiology

THE OSTEOCYTE AS A SIGNALING CELL

Jesus Delgado-Calle, Teresita Bellido

Summary: Osteocytes are multifunctional cells that can regulate bone homeostasis and play a role in various disorders affecting the skeleton. They are also targets and distributors of novel therapies.

PHYSIOLOGICAL REVIEWS (2022)

Article Biochemistry & Molecular Biology

The Notch pathway regulates the bone gain induced by PTH anabolic signaling

Jesus Delgado-Calle, Kevin McAndrews, Gerald Wu, Ashley L. Orr, Adam Ferrari, Xiaolin Tu, Venkatesan Srinivasan, G. David Roodman, Frank H. Ebetino, Robert K. Boeckman, Teresita Bellido

Summary: This study reveals that PTH signaling upregulates Notch pathway components, and Notch activation contributes to the catabolic actions of PTH in bone. Deleting the PTH receptor or overexpressing sclerostin in osteocytes abolishes the increase in Notch components caused by PTH. Moreover, bone-targeted Notch inhibition enhances the bone anabolic effects of intermittent PTH.

FASEB JOURNAL (2022)

Review Oncology

Osteocytes: New Kids on the Block for Cancer in Bone Therapy

Aric Anloague, Jesus Delgado-Calle

Summary: The tumor microenvironment in the bone plays a crucial role in the initiation and progression of cancer. Specifically, the interactions between cancer cells and bone cells, particularly osteocytes, have been identified as key factors in tumor growth and bone disease. Understanding the reciprocal crosstalk between these cells may lead to the development of novel therapeutic strategies for treating bone cancer.

CANCERS (2023)

Article Biochemistry & Molecular Biology

Engineering a Pro-Osteogenic Secretome through the Transient Silencing of the Gene Encoding Secreted Frizzled Related Protein 1

Daniel Garcia-Sanchez, Alberto Gonzalez-Gonzalez, Itziar Alvarez-Iglesias, Monica del Dujo-Gutierrez, Alfonso Bolado-Carrancio, Matilde Certo, Maria Isabel Perez-Nunez, Jose A. Riancho, Jose Carlos Rodriguez-Rey, Jesus Delgado-Calle, Flor Maria Perez-Campo

Summary: The secretome from MSCs in which Sfrp1 has been silenced shows positive effects on bone regeneration by enhancing osteogenic differentiation, decreasing the expression of Wnt inhibitor Dkk1, and inhibiting osteoclastogenesis. The secretome also increases mineralization in human primary MSCs from osteoporotic patients. Proteomic analysis reveals enrichment of osteogenesis-related proteins in the secretome, suggesting that this approach can enhance the osteo-regenerative properties of MSCs' secretome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Osteoclast-derived IGF1 is required for pageticlesion formation in vivo

Kazuaki Miyagawa, Yasuhisa Ohata, Jesus Delgado-Calle, Jumpei Teramachi, Hua Zhou, David D. Dempster, Mark A. Subler, Jolene J. Windle, John M. Chirgwin, G. David Roodman, Noriyoshi Kurihara

JCI INSIGHT (2020)

Article Endocrinology & Metabolism

The Emerging Role of Osteocytes in Cancer in Bone

Emily G. Atkinson, Jesus Delgado-Calle

JBMR PLUS (2019)

Review Endocrinology & Metabolism

Ex Vivo Organ Cultures as Models to Study Bone Biology

Teresita Bellido, Jesus Delgado-Calle

JBMR PLUS (2020)

No Data Available